THE DILEMMAS OF PROSTATE-CANCER
THE DILEMMAS OF PROSTATE-CANCER
复制标题
DOI：
10.1038/scientificamerican0494-72
复制
发表时间：
1994-04-01
影响因子：
3
通讯作者：
GARNICK, MB
中科院分区：
文献类型：
--
作者：
GARNICK, MB
马克·B·加尼克是哈佛医学院达纳-法伯癌症研究所的医学副教授，他在那里照顾泌尿生殖道癌患者。他也是位于马萨诸塞州剑桥市的生物技术公司Genetics Institute，Inc.负责临床开发的副总裁。加尼克是治疗转移性前列腺癌的亮丙瑞林临床测试的领先者，现在正在开发其他药物。
MARC B. GARNICK is associate professor of medicine at the Dana-Farber Cancer Institute at Harvard Medical School, where he cares for patients with genitourinary cancer. He is also vice president of clinical development at Genetics Institute, Inc., a biotechnology firm in Cambridge, Mass. Garnick was a leader in the clinical testing of leuprolide for the treatment of metastatic prostate cancer and is now developing other drugs.